Lunit Highlights AI’s Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies
SEOUL, South Korea, May 23, 2025 — Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the… Read More »Lunit Highlights AI’s Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies